Inventure Revenue and Competitors

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • Inventure's estimated annual revenue is currently $3.5M per year.(i)
  • Inventure's estimated revenue per employee is $92,105

Employee Data

  • Inventure has 38 Employees.(i)
  • Inventure grew their employee count by -21% last year.

Inventure's People

NameTitleEmail/Phone
1
Partner, Co-founderReveal Email/Phone
2
Managing Director, PartnerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M235%$78.9MN/A
#2
$35M17N/AN/AN/A
#3
$3.5M120%N/AN/A
#4
$4.5M32-11%N/AN/A
#5
$3.5M6040%N/AN/A
#6
$7.5M6-40%N/AN/A
#7
$4.1M29-17%N/AN/A
#8
$1.4M100%N/AN/A
#9
$7.5M7-12%N/AN/A
#10
$1.7M580%N/AN/A
Add Company

What Is Inventure?

Inventure invests in nonconformists who build things worth existing. With a dedicated portfolio team, we focus on early-stage fundamentals – talent and expansion. Since 2005, we've had the honor of venturing into the unknown with Nordic and Baltic hyper-growth companies like Blueprint Genetics, Wolt, and Omocom.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$3.5M

Revenue (est)

-21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Inventure News

2022-04-17 - InVenture North seeks board candidates | Community ...

MARINETTE—InVenture North is currently seeking applications for new members of its board of directors to guide the organization's mission...

2022-04-13 - Tech capstone team wins ACC Inventure – Technique

Earlier this month, a group of BMED students was awarded the 2022 ACC Inventure prize. The ACC Inventure event, much like the Georgia Tech...

2022-03-30 - Carotid Artery Closure Device Wins ACC InVenture Prize

Carotid Artery Closure Device Wins ACC InVenture Prize. The group of biomedical engineering undergrads earned $15,000 to help them continue...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.8M38-7%N/A
#2
$6.1M3836%$4.4M
#3
$11.5M3836%N/A
#4
$5.4M39-5%N/A
#5
$3.5M39-26%N/A